Janssen Denied Early Defeat Of HIV Medication FCA Suit
By Dave Simpson (December 21, 2021, 10:52 PM EST) -- A New Jersey federal judge denied drugmaker Janssen Products LP's bid to beat a 9-year-old False Claims Act suit without a trial, ruling Tuesday that there are still many open questions in the suit over whether Janssen benefited from off-label marketing of two medications that can stave off HIV.
U.S. District Judge Zahid N. Quraishi denied Janssen's summary judgment bid, keeping alive the December 2012 lawsuit lodged by two relators on behalf of the government and 27 states under the FCA and federal Anti-Kickback Statute, along with false claims acts in various states, relating to two drugs, Prezista and Intelence. Judge...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!